To our knowledge, this is the first study from Azerbaijan to investigate the MLH1 −93G>A polymorphism in breast cancer patients, offering new evidence on genetic risk within this underrepresented population and contributing to the broader understanding of MMR gene variants in carcinogenesis. The gene discussed is MLH1; the disease is breast cancer.